Subscriber Content Read Preview
Despite a big run-up in its stock already this year, the world's largest spirits maker can still make investors giddy.
Video: A Top-Shelf Stock
Subscriber Content Read Preview
Mark R. Baker sold 12,000 shares of the consumer-fertilizer company.
Subscriber Content Read Preview
Credit Suisse has a soft outlook for natural gas for the rest of the year.
Subscriber Content Read Preview
NutriSystem and Corning rose. Arris Group and St. Jude Medical fell.
Subscriber Content Read Preview
Wall Street is cheering the weight-loss-program provider's distribution deal with Wal-Mart. But investors should think twice before gobbling up shares.
Subscriber Content Read Preview
Jesup & Lamont initiated coverage of the apparel retailer at Buy.
Subscriber Content Read Preview
Morgan Keegan doesn't see any near-term catalysts for the sector.
Subscriber Content Read Preview
Morgan Keegan says the bank is its top pick among regional players.
Subscriber Content Read Preview
AIM's Paul Curbo discusses real-estate stocks that he thinks still offer value.
Subscriber Content Read Preview
Partner Fund Management now holds a 5.1% stake in the drug developer.
Subscriber Content Read Preview
Baird cited a later Labor Day and cooler weather in key regions.
Subscriber Content Read Preview
FBR Capital Markets downgraded the chip giant to Market Perform.
Subscriber Content Read Preview
Although Deutsche Bank upgraded shares of the integrated energy company to Buy from Hold, investors may want to steer clear.
Subscriber Content Read Preview
Credit Suisse cut estimates on some names in the sector.
Subscriber Content Read Preview
The small business lender's debt exchange seems a perilous gamble.
Stocks and exchange-traded funds climb in advance of earnings season. (At SmartMoney.com)
If so, why has it turned into hell for retailers, advertisers and magazine publishers?
Goldman Sachs recommends an options play on the Western banking giant.
Aetna and United Healthcare are among the managed-care stocks that have shown troubling technical signs in recent weeks.
In-depth, comprehensive real-time and daily market data.
Barron's comprehensive collection of weekly data.
Track the performances of stocks Barron's has written about.
Get fundamental analysis of 5,800 stocks plus in-depth reports.
More tools and data:
Live Video News & Markets
Twice Daily from WSJ Digital Network
This feature tracks the performance of stocks Barron's has written about during 2009 -- both favorably and critically. For stocks featured in Barron's print magazine, prices are measured from the Friday before publication date to their current price. For stocks featured on Barrons.com, prices are measured from the trading day of publication date to their current price. This list includes U.S. stocks only, including ADRs, but not foreign stocks.